354200 — NGeneBio Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Market Cap
KR₩42bn
Enterprise Value
KR₩51bn
Revenue
KR₩6bn

Annual balance sheet for NGeneBio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	40,348	24,307	34,918	22,298	7,438
Net Total Accounts Receivable
Net Total Receivables	603	1,661	1,289	1,180	841
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	42,351	27,374	43,072	27,021	11,672
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	5,920	8,092	8,684	9,343	12,172
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	49,393	43,867	56,164	42,282	32,950
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	6,742	8,055	29,001	23,816	12,525
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	7,944	9,869	30,868	25,987	15,973
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	41,449	33,998	25,297	16,295	16,977
Total Liabilities & Shareholders' Equity	49,393	43,867	56,164	42,282	32,950
Total Common Shares Outstanding